Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
26370690
DOI
10.1007/s00134-015-4041-5
PII: 10.1007/s00134-015-4041-5
Knihovny.cz E-zdroje
- Klíčová slova
- Cardiogenic shock, Emergency, Heart failure, Treatment,
- MeSH
- akutní nemoc terapie MeSH
- kardiogenní šok diagnóza terapie MeSH
- lidé MeSH
- péče o pacienty v kritickém stavu normy MeSH
- směrnice pro lékařskou praxi jako téma * MeSH
- srdeční selhání diagnóza terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
PURPOSE: Acute heart failure (AHF) causes high burden of mortality, morbidity, and repeated hospitalizations worldwide. This guidance paper describes the tailored treatment approaches of different clinical scenarios of AHF and CS, focusing on the needs of professionals working in intensive care settings. RESULTS: Tissue congestion and hypoperfusion are the two leading mechanisms of end-organ injury and dysfunction, which are associated with worse outcome in AHF. Diagnosis of AHF is based on clinical assessment, measurement of natriuretic peptides, and imaging modalities. Simultaneously, emphasis should be given in rapidly identifying the underlying trigger of AHF and assessing severity of AHF, as well as in recognizing end-organ injuries. Early initiation of effective treatment is associated with superior outcomes. Oxygen, diuretics, and vasodilators are the key therapies for the initial treatment of AHF. In case of respiratory distress, non-invasive ventilation with pressure support should be promptly started. In patients with severe forms of AHF with cardiogenic shock (CS), inotropes are recommended to achieve hemodynamic stability and restore tissue perfusion. In refractory CS, when hemodynamic stabilization is not achieved, the use of mechanical support with assist devices should be considered early, before the development of irreversible end-organ injuries. CONCLUSION: A multidisciplinary approach along the entire patient journey from pre-hospital care to hospital discharge is needed to ensure early recognition, risk stratification, and the benefit of available therapies. Medical management should be planned according to the underlying mechanisms of various clinical scenarios of AHF.
Anaesthesia and Intensive Care St George's Hospital and Medical School London SW17 0QT UK
Christchurch Cardioendocrine Research Group Christchurch Hospital Christchurch New Zealand
Department of Anesthesia and Critical Care Hôpital Lariboisière APHP Paris France
Department of Cardiology Cumhuriyet University School of Medicine Sivas Turkey
Department of Cardiology Hôpital Lariboisiere APHP Paris France
Department of Cardiology Kaunas University of Medicine Kaunas Lithuania
Department of Emergency and Intensive Care Medicine Paracelsus Medical University Nuremberg Germany
Department of Emergency Medicine Baylor College of Medicine Boston MA USA
Department of Internal Medicine Seoul National University Bundang Hospital Seongnam Korea
Division of Cardiology Massachusetts General Hospital Boston MA USA
Heart and Lung Center Helsinki University Central Hospital Helsinki Finland
Zobrazit více v PubMed
Eur Heart J. 2006 Nov;27(22):2725-36 PubMed
Congest Heart Fail. 2009 Nov-Dec;15(6):256-64 PubMed
JAMA. 2005 Dec 28;294(24):3124-30 PubMed
Eur Heart J. 2008 Apr;29(7):859-70 PubMed
Crit Care Med. 2008 Jan;36(1 Suppl):S129-39 PubMed
Am J Med. 2016 Jan;129(1):96-104.e7 PubMed
Intensive Care Med. 2015 May;41(5):912-5 PubMed
Eur J Heart Fail. 2015 May;17(5):501-9 PubMed
Eur Heart J. 1996 Jan;17 (1):135-42 PubMed
Ann Emerg Med. 1992 Jun;21(6):669-74 PubMed
N Engl J Med. 2010 Mar 4;362(9):779-89 PubMed
N Engl J Med. 1999 Aug 26;341(9):625-34 PubMed
Ann Intern Med. 2010 May 4;152(9):590-600 PubMed
Circulation. 2007 Oct 2;116(14):1549-54 PubMed
Intensive Care Med. 2014 Dec;40(12):1795-815 PubMed
Am Heart J. 2012 Dec;164(6):862-8 PubMed
Am J Cardiol. 2005 Apr 15;95(8):948-54 PubMed
Lancet. 2013 Nov 16;382(9905):1638-45 PubMed
Lancet. 2000 Dec 23-30;356(9248):2126-32 PubMed
Eur J Heart Fail. 2012 Mar;14 (3):278-86 PubMed
N Engl J Med. 2012 Dec 13;367(24):2296-304 PubMed
J Card Fail. 2014 Oct;20(10):723-30 PubMed
Am J Emerg Med. 1999 Oct;17(6):571-4 PubMed
Eur J Heart Fail. 2008 Oct;10(10):933-89 PubMed
Ann Emerg Med. 2007 Aug;50(2):144-52 PubMed
PLoS One. 2014 Nov 11;9(11):e112313 PubMed
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239 PubMed
Circulation. 1999 Mar 2;99(8):1091-100 PubMed
N Engl J Med. 2012 Oct 4;367(14):1287-96 PubMed
Am Heart J. 2009 Sep;158(3):371-7 PubMed
Circulation. 2007 Jun 19;115(24):3103-10 PubMed
Can J Cardiol. 2009 Feb;25(2):85-105 PubMed
J Am Coll Cardiol. 2003 May 21;41(10):1797-804 PubMed
JACC Heart Fail. 2013 Jun;1(3):223-9 PubMed
Lancet. 1998 Feb 7;351(9100):389-93 PubMed
J Am Coll Cardiol. 2002 Oct 16;40(8):1389-94 PubMed
JAMA. 2004 Mar 17;291(11):1358-67 PubMed
J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87 PubMed
Int J Cardiol. 2013 Oct 3;168(3):2186-94 PubMed
Eur J Heart Fail. 2012 Aug;14(8):803-69 PubMed
Intensive Care Med. 2004 Feb;30(2):185-96 PubMed
Br Heart J. 1994 Feb;71(2):146-50 PubMed
N Engl J Med. 2004 Feb 12;350(7):647-54 PubMed
Circ J. 2014;78(4):844-52 PubMed
N Engl J Med. 2008 May 15;358(20):2117-26 PubMed
World J Radiol. 2014 Jun 28;6(6):230-7 PubMed
Am J Respir Crit Care Med. 1997 Nov;156(5):1640-6 PubMed
Nat Rev Cardiol. 2015 Mar;12(3):184-92 PubMed
Ann Emerg Med. 2006 Jan;47(1):13-8 PubMed
Ann Am Thorac Soc. 2014 Jun;11(5):811-22 PubMed
Eur J Heart Fail. 2011 Sep;13(9):961-7 PubMed
Clin Chem. 2010 Dec;56(12 ):1814-21 PubMed
Eur Heart J. 2013 Mar;34(10):742-9 PubMed
Eur Heart J Acute Cardiovasc Care. 2012 Dec;1(4):275-80 PubMed
Am Heart J. 1991 Jun;121(6 Pt 2):1965-73 PubMed
J Card Fail. 2015 Feb;21(2):134-7 PubMed
Congest Heart Fail. 2013 Jul-Aug;19(4):200-6 PubMed
J Card Fail. 2010 Jun;16(6):e1-194 PubMed
Circ Heart Fail. 2015 Mar;8(2):384-409 PubMed
Crit Care Med. 2011 Mar;39(3):450-5 PubMed
J Am Coll Cardiol. 2012 Sep 18;60(12):1031-42 PubMed
PLoS One. 2013 Aug 15;8(8):e71659 PubMed
N Engl J Med. 2013 Dec 5;369(23):2197-206 PubMed
Eur Heart J. 2006 Feb;27(3):330-7 PubMed
Am Heart J. 2014 Apr;167(4):529-36 PubMed
Ann Intensive Care. 2015 Dec;5(1):52 PubMed
Eur J Heart Fail. 2015 Jul;17(7):652-64 PubMed
Eur J Heart Fail. 2006 Nov;8(7):697-705 PubMed
J Am Coll Cardiol. 2004 Feb 18;43(4):635-41 PubMed
Eur Heart J. 2015 May 21;36(20):1223-30 PubMed
Emerg Med J. 2008 Apr;25(4):205-9 PubMed
J Am Heart Assoc. 2015 Jan 05;4(1):e001462 PubMed
Eur Heart J. 2014 Jan;35(3):156-67 PubMed
Intensive Care Med. 2011 Feb;37(2):290-301 PubMed
Eur J Heart Fail. 2010 Nov;12 (11):1253-60 PubMed
Circulation. 2004 Feb 3;109(4):494-9 PubMed
Eur Heart J. 2014 Oct 1;35(37):2541-619 PubMed
Eur Heart J Acute Cardiovasc Care. 2016 Apr;5(2):141-9 PubMed
Heart. 2014 Jan;100(2):115-25 PubMed
Intensive Care Med. 2011 Sep;37(9):1501-9 PubMed
Am Heart J. 2010 May;159(5):841-849.e1 PubMed
J Am Coll Cardiol. 2008 Aug 12;52(7):534-40 PubMed
J Am Coll Cardiol. 2007 Nov 6;50(19):1914-31 PubMed
Acad Emerg Med. 2009 Mar;16(3):201-10 PubMed
J Am Coll Cardiol. 2003 Jun 4;41(11):2010-7 PubMed
Crit Care Med. 2008 Aug;36(8):2257-66 PubMed
Eur J Heart Fail. 2015 Jun;17(6):544-58 PubMed
JAMA. 2007 Mar 28;297(12):1332-43 PubMed
Circulation. 2013 Jan 29;127(4):e362-425 PubMed
Case Rep Crit Care. 2012;2012:262815 PubMed
Eur Heart J. 2012 Sep;33(18):2265-71 PubMed
N Engl J Med. 2008 Jul 10;359(2):142-51 PubMed
Eur J Heart Fail. 2013 Apr;15(4):465-76 PubMed
Rev Cardiovasc Med. 2003;4 Suppl 7:S13-20 PubMed
Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper